• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SISTEMAS MEDICOS ALARIS S.A. DE C.V. BD ALARIS SMARTSITE EXTENSION SET; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SISTEMAS MEDICOS ALARIS S.A. DE C.V. BD ALARIS SMARTSITE EXTENSION SET; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 20127E
Medical Device Problem Code Complete Blockage (1094)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/11/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H.3.If a device evaluation and/or device history review is completed, a supplemental report will be filed.
 
Event or Problem Description
It was reported that bd alaris smartsite extension set was occluded.The following information was received by the initial reporter with the following verbatim: filter was being used to prime with lipids but after passing through the filter, lipids would no longer prime through remaining end of tubing.
 
Event or Problem Description
No additional information.
 
Additional Manufacturer Narrative
Additional information: initial reporter address.Investigation results: it was reported that the lipids would not flow past the filter.One used and one unused sample model 20127e, lot 24039407 was returned for investigation.The set was examined for defects and abnormalities.No defects or abnormalities were observed.The sets were attached to a 10 ml bd syringe filled with water.The unused set was able to be flushed while the used set was unable to be flushed.Visual inspection under the microscope showed signs of excess solvent at the filter port outlet.The customer complaint was verified and a quality notification was sent to the manufacturer.From the manufacturer's investigation, excess solvent can be due to the assembler or issues with the solvent dispenser.A device history record review for model 20127e lot number 24039407 was performed.The search showed that a total of (b)(4) units in 1 lot number was built on 27mar2024.There were no quality notifications issued for the failure mode reported by the customer during the production build of this set.This incident has been added to our database of reported incidents.Our business team regularly reviews the collected data for identification of emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD ALARIS SMARTSITE EXTENSION SET
Common Device Name
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
SISTEMAS MEDICOS ALARIS S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer (Section G)
SISTEMAS MEDICOS ALARIS S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key20233561
Report Number9616066-2024-01321
Device Sequence Number7960843
Product Code FPA
UDI-Device Identifier07613203019248
UDI-Public(01)07613203019248(11)240327(17)270327(10)24039407
Combination Product (Y/N)N
Initial Reporter StateMI
Initial Reporter CountryUS
PMA/510(K) Number
K022209
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 11/15/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue Number20127E
Device Lot Number24039407
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/20/2024
Supplement Date Received by Manufacturer11/15/2024
Initial Report FDA Received Date09/16/2024
Supplement Report FDA Received Date12/09/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/27/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-